General Mills, Inc. (FRA:GRM)

ASLAN Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is June - May.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2025	May 25, 2025	May 26, 2024	May 28, 2023	May 29, 2022	May 30, 2021
Market Capitalization	22,697	25,790	35,524	46,195	39,285	31,460
Market Cap Growth	-27.40%	-27.40%	-23.10%	17.59%	24.87%	-8.47%
Enterprise Value	35,454	38,068	46,745	56,676	50,195	41,298
Last Close Price	42.51	46.09	59.91	72.05	58.14	44.70
PE Ratio	11.26	12.79	15.44	19.06	15.55	16.39
PS Ratio	1.32	1.50	1.94	2.46	2.22	2.12
PB Ratio	2.79	3.17	4.00	4.62	3.90	3.70
P/FCF Ratio	11.22	12.75	15.25	23.67	15.32	15.64
P/OCF Ratio	8.82	10.02	11.68	17.79	12.69	12.85
EV/Sales Ratio	2.13	2.21	2.56	3.02	2.83	2.78
EV/EBITDA Ratio	10.01	11.05	11.70	16.45	13.64	12.26
EV/EBIT Ratio	12.13	12.82	13.41	19.31	15.95	14.37
EV/FCF Ratio	17.53	18.82	20.07	29.04	19.57	20.52
Debt / Equity Ratio	1.66	1.66	1.38	1.13	1.11	1.25
Debt / EBITDA Ratio	3.74	3.74	2.96	3.13	2.91	3.04
Debt / FCF Ratio	6.67	6.67	5.27	5.78	4.36	5.30
Asset Turnover	0.60	0.60	0.63	0.64	0.60	0.58
Inventory Turnover	6.69	6.69	6.34	6.71	6.83	7.19
Quick Ratio	0.29	0.29	0.33	0.36	0.34	0.44
Current Ratio	0.67	0.67	0.65	0.69	0.64	0.70
Return on Equity (ROE)	24.59%	24.59%	24.75%	24.29%	25.84%	24.35%
Return on Assets (ROA)	6.52%	6.52%	7.51%	6.28%	6.70%	6.99%
Return on Capital (ROIC)	8.86%	8.86%	10.34%	8.63%	9.13%	9.48%
Return on Capital Employed (ROCE)	13.30%	13.30%	15.50%	13.10%	14.60%	14.90%
Earnings Yield	8.88%	7.85%	6.48%	5.25%	6.43%	6.10%
FCF Yield	8.91%	7.84%	6.56%	4.23%	6.53%	6.40%
Dividend Yield	5.19%	4.59%	3.63%	2.80%	3.28%	3.71%
Payout Ratio	58.33%	58.33%	54.61%	49.65%	45.97%	53.27%
Buyback Yield / Dilution	3.80%	3.80%	3.61%	1.86%	1.05%	-0.95%
Total Shareholder Return	8.98%	8.39%	7.24%	4.66%	4.32%	2.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.